Format

Send to

Choose Destination
Clin J Am Soc Nephrol. 2019 Sep 6;14(9):1408-1415. doi: 10.2215/CJN.02560319. Epub 2019 Aug 22.

Extracorporeal Removal of Poisons and Toxins.

King JD1,2, Kern MH3,4, Jaar BG5,6,7,8.

Author information

1
Division of Nephrology, University of Maryland, Baltimore, Maryland; JDKing@som.umaryland.edu.
2
Maryland Poison Center, Baltimore, Maryland.
3
Department of Medicine, University Hospital Heidelberg, University of Heidelberg, Heidelberg, Germany.
4
DZHK (German Centre for Cardiovascular Research), Partner Site Heidelberg/Mannheim, Mannheim, Germany.
5
Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.
6
Welch Center for Prevention, Epidemiology and Clinical Research, Johns Hopkins University, Baltimore, Maryland.
7
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland; and.
8
Nephrology Center of Maryland, Baltimore, Maryland.

Abstract

Extracorporeal therapies have been used to remove toxins from the body for over 50 years and have a greater role than ever before in the treatment of poisonings. Improvements in technology have resulted in increased efficacy of removing drugs and other toxins with hemodialysis, and newer extracorporeal therapy modalities have expanded the role of extracorporeal supportive care of poisoned patients. However, despite these changes, for at least the past three decades the most frequently dialyzed poisons remain salicylates, toxic alcohols, and lithium; in addition, the extracorporeal treatment of choice for therapeutic removal of nearly all poisonings remains intermittent hemodialysis. For the clinician, consideration of extracorporeal therapy in the treatment of a poisoning depends upon the characteristics of toxins amenable to extracorporeal removal (e.g., molecular mass, volume of distribution, protein binding), choice of extracorporeal treatment modality for a given poisoning, and when the benefit of the procedure justifies additive risk. Given the relative rarity of poisonings treated with extracorporeal therapies, the level of evidence for extracorporeal treatment of poisoning is not robust; however, extracorporeal treatment of a number of individual toxins have been systematically reviewed within the current decade by the Extracorporeal Treatment in Poisoning workgroup, which has published treatment recommendations with an improved evidence base. Some of these recommendations are discussed, as well as management of a small number of relevant poisonings where extracorporeal therapy use may be considered.

KEYWORDS:

toxicology; extracorporeal therapies; hemodialysis; poisoning; intoxication; acidosis; therapeutic plasma exchange; toxic alcohols; lithium; salicylates; Poisons; Toxins, Biological; hemoperfusion

PMID:
31439539
PMCID:
PMC6730523
[Available on 2020-09-06]
DOI:
10.2215/CJN.02560319

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center